Development

Articles

The $72-million investment, part of a larger $850-million investment into its US operations, will allow the drugmaker to replace an outdated insulin vial-filling line and to upgrade technology at its Indianapolis manufacturing plant.

Lilly to Invest $72 Million for Insulin Manufacturing Upgrade

West will be showcasing its range of packaging components and drug delivery solutions, including NovaPure components, LyoSeal caps, and the SmartDose platform.

West Presents Innovations for Packaging Challenges at CPhI Worldwide 2017

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Safe and effective drug targeting with ADCs requires careful selection of drug, antibody, and linker.

Targeting Drug Delivery with ADCs

Joerg Zimmermann is director of Process Development and Implementation at Vetter, www.vetter-pharma.com

Prefilled dual-chamber cartridges offer several advantages. Several steps should be taken to determine if a dual-chamber system is viable for a lyophilized injectable drug product.

Developing an Injectable Compound for a Dual- Chamber Delivery System

Researchers test the efficacy of a new polymer that is an alternative to PEG for drugs used to treat type 2 diabetes.

Duke Researchers Test PEG-Alternative as a New Drug Delivery Technology

A variety of strategies have been employed to deliver proteins and peptides in improved parenteral formulations and/or via noninvasive routes.

Advances in Delivering Protein and Peptide Therapeutics

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

A new study proposes a new way to potentially treat congenital diseases in utero.

Study Demonstrates Potential Method for Treating Congenital Diseases In Utero

West will showcase several drug-delivery systems and packaging component technologies such as its NovaPure plungers and SmartDose technology platform.

West Features Injectable Packaging and Drug-Delivery Innovations at CPhI 2016

Aptar Pharma has signed a license agreement with BD to jointly develop and bring a new autoinjector to market.

Aptar Pharma Forms Pact with BD to Develop Novel Autoinjector

Experts discuss the key considerations in the development of an autoinjector.

Formulation and Drug Delivery, Parenterals